Not Logged In
Project Navigator
Ivermectin has been given safely to over a billion people for parasitic disease. Scabies causes enormous suffering in crowded, low-income settings, yet attracts little research money because the patients are poor. Open question: does a periodic community-wide ivermectin dosing schedule interrupt scabies transmission cost-effectively? Fund an implementation trial in a high-burden community.
Pledged: $0.00 |
Committed: $0.00 |
Released: $0.00
Sub-Projects
No projects yet.